Production (Stage)
AxoGen, Inc.
AXGN
$11.07
$0.131.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 48.56M | 49.41M | 48.64M | 47.91M | 41.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.56M | 49.41M | 48.64M | 47.91M | 41.38M |
| Cost of Revenue | 13.63M | 11.83M | 12.21M | 12.57M | 8.76M |
| Gross Profit | 34.93M | 37.58M | 36.44M | 35.35M | 32.62M |
| SG&A Expenses | 30.50M | 28.85M | 29.76M | 29.12M | 29.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.22M | 47.39M | 48.96M | 48.34M | 45.94M |
| Operating Income | -1.66M | 2.02M | -316.00K | -428.00K | -4.56M |
| Income Before Tax | -3.83M | 450.00K | -1.86M | -1.92M | -6.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.83M | 450.00K | -1.86M | -1.92M | -6.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.83M | 450.00K | -1.86M | -1.92M | -6.64M |
| EBIT | -1.66M | 2.02M | -316.00K | -428.00K | -4.56M |
| EBITDA | 134.00K | 3.72M | 1.40M | 1.31M | -2.98M |
| EPS Basic | -0.08 | 0.01 | -0.04 | -0.04 | -0.15 |
| Normalized Basic EPS | -0.05 | 0.01 | -0.03 | -0.03 | -0.10 |
| EPS Diluted | -0.08 | 0.01 | -0.04 | -0.04 | -0.15 |
| Normalized Diluted EPS | -0.05 | 0.01 | -0.03 | -0.03 | -0.10 |
| Average Basic Shares Outstanding | 45.20M | 44.88M | 43.88M | 43.71M | 43.23M |
| Average Diluted Shares Outstanding | 45.20M | 48.06M | 43.88M | 43.71M | 43.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |